You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昆藥集團(600422.SH):擬17.91億元收購華潤聖火51%股權

格隆匯6月7日丨昆藥集團(600422.SH)公佈,為落實公司戰略規劃,實現公司三七業務戰略性、專業化整合,助力公司打造三七產業鏈標杆企業,進一步提升公司在心腦血管領域產品的市場份額,實現將公司打2造成為“銀髮健康產業引領者、精品國藥領先者、老齡健康-慢病管理領導者”的戰略目標;公司擬與關聯方華潤三九簽署股權轉讓協議,以自有或自籌資金人民幣17.91億元收購華潤三九持有的華潤聖火51%股權。

本次交易是公司實現三七業務整合的重要舉措,將有利於公司通過對三七業務產業鏈整合和佈局優化,實現公司三七業務戰略性、專業化整合,助力公司打造三七產業鏈標杆企業,成為“三七產業”規範發展的主導力量,推動以“三七”為代表的傳統中藥產業鏈高質量發展;充分發揮公司與標的公司在產品、渠道、品牌、供應鏈等方面的協同優勢,不斷提升公司在心腦血管疾病治療領域業務規模,持續增厚公司“老齡健康-慢病管理”領域的業績;並可以解決公司與華潤三九在血塞通軟膠囊產品上的同業競爭問題。本次交易符合公司未來五年(2024-2028年)戰略規劃,有助於實現將公司打造成為“銀髮健康產業引領者、精品國藥領先者、老齡健康-慢病管理領導者”的戰略目標,有利於公司長期可持續穩健發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account